Treatment of Asthma Attack in Children

Yıl 2019, Cilt: 11 Sayı: 2, 58 - 63, 07.03.2019

Prof. Dr. Haluk Çokuğraş

Öz

Abstract

Asthma is the most frequently seen chronic disease in childhood. Asthmatic exacerbation is a major cause for patients to visit emergency services and may even cause hospitalization. Asthma exacerbation could be seen different clinic severity from mild to lifethreatening. It should be kept in mind that patients with mild asthma have a serious risk of attack and risk of mortality. Quick anamnesis, physical examination and assesment theseverity of exacerbations followed by early initiation of the therapy, is the simple algorithm for approaching asthma exacerbations. Since the children who are older than 5 years different both anatomically and physiologically from younger ones while determining the treatment plan patient’s age should be taken into consideration.

Anahtar Kelimeler

Asthma, attack, children

Çocuklarda Astımda Atak Tedavisi

Öz

Öz

Astım, çocukluk çağının en sık kronik hastalığıdır. Astım atakları acil servis başvuruları ve hastane yatışlarının önemli bir nedenidir. Astım atakları hafiften, hayatı tehdit edecek şiddette farklı klinik ağırlıkta olabilir. Hafif astımlı hastaların da cid-di atak tehlikesi taşıdığı ve mortalite riski olduğu unutulmamalıdır. Atakta olan her hastanın öncelikle kısa öyküsü alınarak, muayenesi yapılmalı, atak şiddeti belirlenmeli ve hızlıca tedaviye başlanmalıdır. Beş yaş altında ve üstünde olan çocukların anatomik ve fizyolojik özellikleri birbirinden farklı olduğundan tedavi planı belirlenirken hastanın yaşı göz önünde bulundurulmalıdır.

Anahtar Kelimeler

Astım, atak, çocuk

Kaynakça

• Kaynaklar 1.Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA,Busse WW, et al. An official American Thoracic Society/Euro-pean Respiratory Society statement: asthma control and exa-cerbations: standardizing endpoints for clinical asthma trialsand clinical practice. Am J Respir Crit Care Med 2009;180:59-99. https://doi.org/10.1164/rccm.200801-060ST 2.Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, GernJ, Lemanske R, et al. International consensus on (ICON) pedi-atric asthma. Allergy 2012; 67:976-97.https://doi.org/10.1111/j.1398-9995.2012.02865.x 3.Global Initiative for Asthma (GINA) Program 2018. 4.Brunette mG1, Lands L, Thibodeau LP. Childhood asthma:prevention of attacks with short-term corticosteroid treatmentof upper respiratory tract infection. Pediatrics 1988;81:624-9. 5.Bisgaard H, Hermansen mN, Loland L, Halkjaer LB, BuchvaldF. Intermittent inhaled corticosteroids in infants with episodicwheezing. N Engl J Med 2006 11;354:1998-2005.https://doi.org/10.1056/NEJMoa054692. 6.Connett G, Lenney W. Prevention of viral induced asthma at-tacks using inhaled budesonide. Arch Dis Child 1993;68:85- 7.https://doi.org/10.1136/adc.68.1.85.7.Robertson CF,Price D,Henry R,Mellis C,Glasgow N,Fitzgerald D etal.Short course montelukast for intermittant asthma in clildren:a ran-domize controlled trial.Am J Respir Crid Care Med 2007;175:323-9. 8.Bacharier LB,Phillips BR,Zeiger RS,Szefler SJ,MartinezFD,Lemanske LF et al.Episodic use of an inhaled corticosteroid or leukotriene receptor antagonistin preschool childrenwithmoderate to severe intermittant wheezing.J Allergy Clin İmmu-nol 2008;122:1127-35 e8. 9.Guidelines for the Diagnosis and Management of Asthma (ExpertPanel Report 3) National Heart, Lung, and Blood Institute-2007. 10.Griffiths B, Ducharme Fm. Combined inhaled anticholinergicsand short-acting beta2-agonists for initial treatment of acuteasthma in children. Cochrane Database Syst Rev 2013;8:CD000060. 11.Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, CamargoCA. Magnesium sulfate for treating exacerbations of acuteasthma in the emergency department. Cochrane Database SystRev 2000;CD001490.https://doi.org/10.1002/14651858.cd001490. 12.Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers)versus nebulisers for beta-agonist treatment of acute asthma.Cochrane Database Syst Rev 2013.https://doi.org/10.1002/14651858.CD000052.pub3. 13.Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-ago-nists in the treatment of acute adult asthma: a systematic revi-ew with meta-analysis. Chest 2002; 122:160-5. 14.Camargo CA, Jr, Spooner CH, Rowe BH. Continuous versus inter-mittent beta-agonists in the treatment of acute asthma. Cochrane Da-tabase Syst Rev 2003:CD0011 15.Travers AH, milan SJ, Jones AP, Camargo CA, Rowe BH. Ad-dition of intravenous beta(29-agonist to inhaled beta(2)-ago-nist for acute asthma. Cochrane Database Syst Rev2012;12:CD010179 16.Vezina K, Chauhan BF, Ducharme Fm. Inhaled anticholiner-gics and short-acting beta(2)-agonists versus shortactingbeta2-agonists alone for children with acute asthma in hospi-tal. Cochrane Database Syst Rev 2014;7:Cd010283 17.Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenousmagnesium sulphate for treating acute asthma. Arch Dis Child2005;90:74-7. https://doi.org/10.1136/adc.2004.050005 18.Jat KR, Chawla D. Ketamine for management of acute exacer-bations of asthma in children. Cochrane Database Syst Rev2012;11:CD009293.https://doi.org/10.1002/14651858.cd009293.pub2 19.Foster JM, Hoskins G, Smith B, Lee AJ, Price D, Pinnock H.Practice development plans to improve the primary care mana-gement of acute asthma: randomised controlled trial. BMCFam Pract 2007:24;8:23.